b-Catenin is a biologically important molecule playing critical roles in both cell adhesion and transcriptional regulation in the Wnt pathway. Here, we show that phospho-b-catenin (phosphorylated at Ser33/37/Thr41), which is reported to be degraded immediately after its phosphorylation, accumulated in the centrosome. Whereas phospho-mimicking mutant, S33/37/T41E-b-catenin, could localize to the centrosome, S33A-b-catenin that lacks the phosphorylation site lost its localization to the centrosome. Phospho-b-catenin localized mainly to mother centrosome during the interphase and was recruited to daughter centrosome in M-phase. Depletion of b-catenin with small interfering RNA or inhibition of its phosphorylation by LiCl treatment caused disruption of radial microtubule (MT) array and retardation of the MT regrowth during the recovery from nocodazole treatment. In addition, these treatments increased the frequency of mono-astral MT reorganization. Furthermore, overexpression of the nonphosphorylatable b-catenin, but not the phospho-mimicking b-catenin, markedly disrupted radial MT array and repressed the MT regrowth. In contrast, phospho-mimicking b-catenin localized to both of the duplicated centrosomes with aberrant larger and denser radial MTs array formation. In addition, some of the cells overexpressing phospho-mimicking b-catenin had multiple centrosomes. Taken together, this study demonstrates a novel role of phospho-b-catenin in MT organization at the centrosomes.
Introduction
Traditional Wnt/b-catenin signal transduction pathway plays key role in embryonic development and cancer progression through b-catenin-regulated gene expression (Huelsken and Behrens, 2002) . Recent studies, however, have shown that some components of Wnt pathway regulate microtubule (MT) function (Gundersen and Cook, 1999; Harwood and Braga, 2003) . GSK3b itself is present along spindle MTs (Wakefield et al., 2003) and can regulate the phosphorylation of some MT-binding proteins such as tau, adenomatous polyposis coli (APC), MAP1B to affect the stability of MTs (Lucas et al., 1998) . Another key component of Wnt pathway, APC, binds to the plus ends of MTs and stabilizes the growing ends (Zumbrunn et al., 2001) . Similarly, Dishevelled-1, an upstream molecule of b-catenin, is involved in the regulation of MT stability (Krylova et al., 2000; Ciani et al., 2003) . b-Trcp1 may also regulate the timely order of meiotic and mitotic events (Guardavaccaro et al., 2003) .
Many b-catenin-binding proteins are also involved in the regulation of the function of MTs. Dynein binds to b-catenin and may tether MTs at adherens junctions. Overexpression of b-catenin disrupts the cellular localization of dynein and dramatically perturbs both the organization of MTs at the centrosome and the tethering of MTs at adherens junctions (Ligon et al., 2001) . b-Catenin, APC, KAP3 and KIF3A-KIF3B are in the same complex in vivo, and both APC and b-catenin are transported along MTs assisted by KAP3-KIF3A-KIF3B (Jimbo et al., 2002) . Another b-cateninbinding protein, EB1, is required for the formation and maintenance of the radial MT array anchored at the centrosome (Askham et al., 2002) . A recent paper has provided direct evidence that b-catenin is associated with the establishment of bipolar mitotic spindle (Kaplan et al., 2004) . In addition, b-catenin itself is reported to be associated with the regulation of the cell cycle. The level of b-catenin increases in S phase, reaching maximum accumulation at late G2/M. Overexpression of a nonphosphorylatable mutant b-catenin in epidermal keratinocyte induces G2 arrest (Olmeda et al., 2003) . All these studies above indicate a possible role of b-catenin on the regulation of the MT function during the cell cycle.
In this report, we show that phospho-b-catenin is localized to mother centrosome during the interphase and distributed to both mother and daughter centrosomes in M-phase. Furthermore, we found phospho-bcatenin plays a role on the maintenance of radial MT array during the interphase by anchoring MT to the centrosome.
Results
Phospho-b-catenin localizes mainly to mother centrosome during the interphase We first investigated the subcellular localization of b-catenin and its phosphorylated form in rat fibroblast cell line, 3Y1. In normal cells, b-Catenin appears to be distributed mainly in the membrane and diffusely throughout the cytoplasm (Sadot et al., 2002) . b-catenin is phosphorylated by GSK-3b at Ser33, 37 and Thr41, and ubiquitinated by b-Trcp1 and degraded in a proteasome-dependent pathway. However, we found that phospho-b-catenin was localized at microtubule organizing center (MTOC) (Figure 1a) . Interestingly, phospho-b-catenin was localized to only one of the two centrosomes in cells (Figure 1b) . Deconvolution analysis showed that phospho-b-catenin enveloped the centrosome (Figure 1b) , which is similar to the localization of MT anchor proteins such as ninein and CEP100 (Ou et al., 2002) . As phospho-b-catenin is localized to only one of the two centrosomes (Figure 1b) , we checked whether it is mother centrosome or not by staining with Phospho-b-catenin and microtubule regrowth P Huang et al a mother centrosome marker, e-tubulin. We found the co-localization of phospho-b-catenin with e-tubulin ( Figure 1c ). EB1 localizes to the mother centrosome and C-terminus of EB1 interacts with b-catenin (Askham et al., 2002) . We also observed co-localization of EB1 and phospho-b-catenin (Figure 1d ). However, we could not detect direct interaction of phospho-b-catenin with e-tubulin and EB1 by immunoprecipitation (Supplementary Figure S1a ). The phospho-b-catenin antibody has been reported to detect specifically phosphorylated b-catenin (Kielhorn et al., 2003) , and we confirmed that this antibody did not detect mutant b-catenin (S33A) whose Ser33 was replaced with alanine ( Figure 2a ). To confirm phosphorylation-dependent localization of b-catenin to the centrosome, we constructed a phospho-mimicking mutant b-catenin whose Ser33, 37 and Thr41 were replaced to glutamic acid (S33/37/T41E) and transfected it to COS7 cells. Substitution of serine or threonine to glutamic acid is known to mimic phosphorylation. Although S33/37/T41Eb-catenin localized to the centrosome, we could not see any localization of S33Ab-catenin to the centrosome (Figure 2b arrowhead) . These results with mutant b-catenins are consistent with our Phospho-b-catenin and microtubule regrowth P Huang et al observation that phospho-b-catenin localizes to the centrosome. In contrast to endogenous wild-type phospho-b-catenin localized to the mother centrosome, S33/37/T41E mutant unexpectedly localized to both of the duplicated centrosomes visualized with g-tubulin.
Moreover, we observed that some of the cells overexpressing S33/37/T41Eb-catenin had multiple centrosomes, every one of which had association of S33/37/ T41Eb-catenin (Figure 2c ).
Phospho-b-catenin is recruited to daughter centrosome in M-phase We next examined the localization of phospho-b-catenin in various cell-cycle stages. We found that, upon the onset of M-phase, phospho-b-catenin was distributed to both mother and daughter centrosomes (Figure 3a) . Consistent with this observation, there was a dramatic increase of phospho-b-catenin at G2/M-phase, as compared with that at G1-phase (Figure 3b ). We also found that phospho-b-catenin was present at both centrosomes throughout the whole M-phase (Figures 3c and Supplementary Figure S2a) . This distinctive distribution pattern led us to speculate that it may take a role in daughter centrosome maturation and spindle pole formation. As cells progressed to late telophase, phosphob-catenin accumulated at mid-body, indicating a possible localization of phospho-b-catenin to the plus ends of the MTs. Phospho-b-catenin and microtubule regrowth P Huang et al
Phospho-b-catenin pool is upregulated in cell cycle-dependent manner As b-catenin is hardly detectable owing to the immediate degradation in the cytoplasm after its phosphorylation at S33 (Sadot et al., 2002) , we carefully investigated the subcellular localization and the protein level of b-catenin and phospho-b-catenin during the cell cycle.
The proportion of each cell phase at 0, 3, 6, 9 and 12 h after release from double thymidine block was indicated in Supplementary Figure S3 . b-Catenin relocalized to the nucleus from S phase. This relocalization continued from S phase to G2/M-phase so that nuclear b-catenin clearly increased in G2/M-phase cells, as compared with those in G1-phase cells (Figure 4a ). Phospho-b-catenin started to accumulate in the nucleus at S phase and reached plateau at G2/M-phase. Consistently, the protein level of phospho-b-catenin increased 3 h after the release from thymidine block and decreased 12 h after the release when cyclin B1 has also decreased ( Figure 3b ). As the phosphorylation of b-catenin is regulated by GSK-3b, we determined the localization of phospho-b-catenin and GSK-3b during the cell cycle. As shown in Figure 4c , GSK-3b started to accumulate in the nucleus at S phase and localized exclusively in the nucleus at G2/M-phase as reported previously (Tang et al., 2003) . The accumulation of GSK-3b in the nucleus preceded that of phospho-b-catenin as well as b-catenin. LiCl that inhibits GSK-3b activity impeded the cell cycle-dependent increase of phospho-b-catenin ( Figure 4b ). Taken together, cell cycle-dependent phosphorylation of b-catenin is likely to be regulated by GSK-3b.
Depletion of b-catenin suppresses radial MT array anchoring at centrosome As fibroblast radial MTs anchor at mother centrosome where phospho-b-catenin is localized during the interphase, we next examined the effect of depletion of b-catenin on the formation of radial MT array. As shown in Figure 5a , the total protein level of b-catenin was reduced greatly by treatment with small interfering RNA (siRNA) targeting b-catenin. We found that in cells whose b-catenin was not depleted, the majority of MTs focused on the centrosome and was organized into well-defined radial arrays. In contrast, in cells whose b-catenin was substantially depleted, MTs did not form radial arrays nor converge on the centrosome but were randomly organized in the cytoplasm (Figure 5b ). Sixty-nine percent of cells treated with b-catenin siRNA showed defects in MT anchoring at the centrosome, but only 8.7% of cells treated with control siRNA had the defects of MT anchoring ( Figure 5c ). These results suggest that b-catenin is required for MTs anchoring at the centrosome. We next examined whether the depletion of b-catenin had the effect on the localization of other centrosomal proteins. As shown in Supplementary Figure Depletion of b-catenin retards the MT regrowth at the centrosome To obtain more clues, we next examined the dynamics of phospho-b-catenin localization during MT reorganization by treatment with nocodazole. In control cells, part of phospho-b-catenin was localized at the perinuclear region, which almost overlapped with the localization of radial MT array. This perinuclear phospho-b-catenin was disappeared when MTs were depolymerized by nocodazole. After washing out of nocodazole, phosphob-catenin was recruited to the peripheral area of the centrosome along with the regrowth of MT network (Figure 6a, arrowhead) . This localization mode of phospho-b-catenin is similar to that of proteins associated with spindle pole formation such as dynein and dynactin (Quintyne and Schroer, 2002) . We next examined the effect of b-catenin depletion on MT reorganization. Although, 2 min after nocodazole washout, nucleation of MTs was observed in cells depleted of b-catenin, it was smaller than that of control cells. Fifteen minutes after nocodazole washout, control cells showed fine MT aster formation. In contrast, MT regrowth was clearly retarded in cells depleted of b-catenin (Figure 6b , arrowhead). MT regrowth was quantified when the intensity of MT aster reached maximum after 30 min of nocodazole washout. The fluorescent intensity of visualized MT (a-tubulin staining) in cells treated with b-catenin siRNA was decreased to 56% of normal cells (Figure 6c and d) . MT asters were then organized into radial MT arrays at 60 min after nocodzole washout (Figure 6e ). In normal cells at 60 and 90 min after nocodzole washout, we observed a fine radial MT array formation focusing at centrosome where phospho-b-catenin was localized. In contrast, MTs did not form clear radial arrays but were randomly formed in the cytoplasm in b-catenin-depleted cells (Figure 6e ).
MTs are generally associated only with mother centrosomes and young daughter centrosomes are not yet competent to organize MTs (Piel et al., 2000) . We visualized the centrosome by staining g-tubulin and investigated the MTs reorganization in cells that has two centrosomes (the distance between two centrosomes separated over 5 mm). Sixty-three percent of control cells treated with siRNA had MT reorganization from both centrosomes, whereas 37% of cells had MT Phospho-b-catenin and microtubule regrowth P Huang et al reorganization from only one of the centrosomes. When cells were treated with b-catenin siRNA, 65% of cells had MT reorganization from only one of the centrosomes (Figure 6f and g ). These results suggest that maturation of centrosomes was inhibited by depletion of b-catenin and thus mono-astral MTs increased. Figure S4b) . We checked whether the centrosomal localization of phospho-b-catenin was associated with the formation of radial MT array. We found that cells whose centrosomal phospho-b-catenin was reduced by LiCl treatment had no organized radial MT array anchoring at the centrosome, whereas cells with phospho-b-catenin at the centrosome had organized radial Mt arrays (Figure 7a ). We also examined the effect of LiCl treatment on the reorganization of MTs after nocodazole washout. Twenty-four hours after LiCl treatment, MT regrowth was remarkably repressed (Supplementary Figure S5) . MT fibers regrew from the centrosome Figure S5) . Interestingly, Phospho-b-catenin and microtubule regrowth P Huang et al short-time LiCl treatment caused an acceleration of the reorganization of MT array (data not shown), which may reflect a stabilization of the MT owing to the decreased phosphorylation of tau and APC (Lucas et al., 1998) . We also observed that LiCl treatment increased the number of mono-aster MT, a phenotype similarly observed in b-catenin-depleted cells (Figure 7b and c) , possibly by inhibiting the maturation of the centrosome. Phospho-b-catenin and microtubule regrowth P Huang et al radial MT array. The formation of radial MT array was disrupted in cells expressing GFP-S33Ab-catenin, whereas the radial MT array was well formed in cells expressing GFP-S33/37/T41Eb-catenin (Figure 8a ). Whereas 90% of cells (n ¼ 100) expressing GFPS33Ab-catenin could not form radial MT array, only 27% of cells (n ¼ 100) expressing GFP-S33/37/T41Eb-catenin could not form radial MT array as measured by the quantitative assay. We also observed larger and denser formation of radial MT array in some cells expressing GFP-S33/37/T41Eb-catenin (Figure 8a , bottom panel and Supplementary Figure S6a) , suggesting that this phospho-mimicking mutant b-catenin may strengthen the formation of radial MT array. We could clearly observe that S33/37/T41E mutant displayed two dots distribution at the center of radial MT array (Figure 8a, inset) . Strikingly, in some cases, we found that S33/37/T41E mutant formed a ring structure but not the dot one at the centrosome (Supplementary Figure S6b) , overlapping the localization of MTOC, whose structure was also deformed from the dot type to a ring one, strongly supporting that phospho-b-catenin was involved in the MTOC function. We next examined the effect of both mutants on MT reorganization. COS7 cells were transfected with S33Ab-catenin or S33/37/ T41Eb-catenin and treated with nocodazole. As shown in Figure 8b , at 60 min after nocodazole washout, cells expressing S33/37/T41E showed clear formation of radial MT array, whereas radial MT array formation was clearly impaired in cells that express S33Ab-catenin. We also observed that overexpression of S33A, but not S33/37/T41E, resulted in the delay or complete abrogation of MTs regrowth at 30 min after nocodazole washout (Supplementary Figure S6c) .
Discussion
In addition to its critical role in cell adhesion and transcriptional regulation, Kaplan et al. (2004) reported that b-catenin localized to spindle poles and played a role in the establishment of a bipolar mitotic spindle. In this study, we showed that phospho-b-catenin was present at mother centrosome during the interphase and localized to both of the two centrosomes upon entry into M-phase. This distribution pattern is similar to the localization of the MT anchors such as ninein and CEP100 (Ou et al., 2002) , which indicates a potential function of phospho-b-catenin on MT anchoring and centrosome maturation. Depletion of b-catenin by siRNA or inhibition of the phosphorylation of b-catenin by LiCl causes loss of radial MTs array focusing at the centrosome, indicating a role of phospho-b-catenin on MT array anchoring at the centrosome. Furthermore, overexpression of nonphosphorylatable S33Ab-catenin causes disruption of radial MTs array focusing at the centrosome, whereas overexpression of phospho-mimicking S33/37/T41Eb-catenin does not disrupt radial MTs array focusing at the centrosome. Although we could not clarify the mechanism, some of the cells expressing phospho-mimicking mutant had aberrant larger and denser radial MTs array formation. In mitosis, phospho-b-catenin localizes to both centrosomes/spindle poles. b-Catenin siRNA-induced monoastral spindle, and both b-catenin siRNA and LiCl increased frequency of mono-astral MT reorganization after nocodazole washout, suggesting that phospho-bcatenin has a potentially important function on centrosome maturation. In fact, when GSK-3b is inhibited, additional long MTs were formed from one pole and many of the chromosomes were mono-oriented (Wakefield et al., 2003) . Our findings perhaps provide more reasonable explanation for this asymmetrical effect of GSK-3b inhibition on centrosomes.
GSK-3b-dependent phosphorylation of b-catenin is upregulated in G2/M-phase. On the other hand, the inactive phosphorylated form of GSK-3b is also increased in G2/M-phase. We examined the localization of phospho-GSK-3b and compared with that of GSK3b, which is mostly unphosphorylated. Whereas most of the phospho-GSK-3b localized in the cytoplasm throughout the cell cycle (Supplementary Figure S2b) , unphosphorylated GSK-3b was translocated to the nucleus from S phase to G2/M-phase. It is likely that active form of GSK-3b in nucleus increases from S phase to G2/M-phase. Indeed, GSK-3b appears to phosphorylate cyclin D in the nucleus in S phase which in turn translocates phosphorylated cyclin D to the cytoplasm (Diehl et al., 1998) . These results support the idea that GSK-3b in the nucleus remains active. It is likely that b-catenin is phosphorylated by GSK-3b in the nucleus, where it is protected from the degradation and accumulated until mitosis and then released to the cytoplasm when nuclear membrane is broken. Although phospho-b-catenin has a short half-life, degradation of phospho-b-catenin appears to be determined by the subcellular localization (Sadot et al., 2002) . It should be noted that the subcellular distribution of the b-catenin destruction complex is mostly localized in the cytoplasm (Reinacher-Schick and Gumbiner, 2001) . Nuclear accumulation of phospho-b-catenin in G2/M may, therefore, protect it from degradation. In fact, when cells enter into the next G1-phase, phospho-b-catenin released to the cytoplasm is rapidly degraded (Figure 3b) . It is consistent with a previous report that soluble b-catenin levels showed dynamic changes: a five to six-fold increase at G2/M-phase followed by a quick decrease of b-catenin after reentering into G1-phase (Olmeda et al., 2003) .
It remains to be clarified whether b-catenin is phosphorylated at the centrosome or translocated to the centrosome after phosphorylation. It has been reported that phospho-GSK-3b that is inactive is abundant at the centrosome and spindle poles. We found that GSK-3b is not present at the centrosome during the interphase when phospho-b-catenin is present at the centrosome. Phospho-b-catenin may be, therefore, translated to the centrosome after phosphorylation by unknown mechanism.
As b-catenin plays critical roles in both cell adhesion and transcriptional regulation in the Wnt pathway, its function has been studied in this context. b-Catenin localizes to the plasma membrane where it associates with dynein and controls MT anchoring at the adherence junction (Ligon et al., 2001) . Because of these observations, a possibility arose that disruption of MT anchoring at the adherence junction subsequently caused disorganization of MT. In a single isolated cell, however, b-catenin is not involved in cell-cell adhesion; yet, MT arrays were clearly organized in these cells (Supplementary Figure S4c) . After transfection of siRNA against b-catenin, some cells lost b-catenin at the plasma membrane but MT array were still clearly organized (Supplementary Figure S4d) . Therefore, the disruption of MT array may be a direct effect of phospho-b-catenin depletion rather than the secondary effect caused by the loss of cell-cell adhesion. Moreover, it should be noted here that cells treated with LiCl had large amount of b-catenin localized at adherence junction but failed to form the radial MT array (Supplementary Figure S4b) , suggesting again that bcatenin localized at adherence junction alone is not sufficient for the formation of radial MT array.
In the canonical Wnt pathway, b-catenin plays a central role in regulating gene expression. GSK-3b and APC are involved in Wnt pathway by regulating b-catenin degradation. However, in the noncanonical Wnt pathway, GSK-3b and APC are localized at the centrosome and have a direct role on the regulation of MT cytoskeleton (Harwood and Braga, 2003) . Inhibition of GSK-3b or truncations of APC cause abnormal mitosis, which is considered as an effect on the formation of mitotic spindle but not an effect on gene expression mediated by b-catenin. Inhibition of GSK-3b or truncations of APC promotes the elevation of b-catenin and its mediated gene expression. Since phospho-b-catenin localizes at the centrosome, the MT disorganization caused directly by the depletion of b-catenin. It has been reported that a dominant-negative mutant of T-cell factor (TCF) that blocked b-cateninmediated transcriptional activation could not induce the formation of mono-astral spindles (Kaplan et al., 2004) . Furthermore, blocking all transcriptional activity by treatment of cells with actinomycin D did not abrogate the MTs stabilization function of dishevelled (DVL) (Ciani et al., 2003) . To rule out the involvement of b-catenin transcriptional activity in the MT reorganization, we examined the cells treated with actinomycin D. We found that actinomycin D neither disrupt MT focused at the centrosome nor inhibited the MT regrowth after nocodazole washout (data no shown). In addition, both LiCl treatment and overexpression of S33A mutant, which increased the accumulation of b-catenin thereby upregulated b-catenin-mediated gene expression, resulted in disorganized MT and suppression of MT regrowth. We, therefore, suggest that the transcriptional process controlled by b-catenin is dispensable for its function in MT dynamics.
The localization and phosphorylation of b-catenin were regulated in a cell cycle-dependent manner (Figure 4a) , suggesting that the localization and phosphorylation of b-catenin should be spatiotemporally controlled by the cell cycle. Our results are consistent with the previous report (Olmeda et al., 2003) . Interestingly, we found that most of the cells overexpressing wild-type b-catenin or nonphosphorylatable S33Ab-catenin formed abnormal nuclei (data not shown). On the other hand, cells overexpressing phospho-mimicking S33/37/T41Eb-catenin also frequently displayed aberrant MT network and abnormal nucleus (data not shown). These results suggest that aberrant accumulation of phospho-b-catenin may also cause aberrant MT formation, which, in turn, yields the formation of abnormal nucleus. Indeed, cell transformation with v-src causes aberrant accumulation of phospho-b-catenin and abnormal nucleus formation with multiple centrosomes (data not shown). Aberrant expression of centrosomal proteins is frequently observed in cancers and overexpression of centrosomal kinase such as Nek2 causes accumulation of multinucleated cells with supernumerary centrosomes (Hayward et al., 2004) . It is widely accepted that centrosomal abnormalities increases the genomic instability which in turn, contributes to tumorigenicity (Pellman, 2001; Nigg, 2002; Sluder and Nordberg, 2004) . In fact, high levels of nuclear phospho-b-catenin are associated with significantly worse survival in malignant melanoma (Kielhorn et al., 2003) . Transcriptional upregulation of cell proliferation genes such as cyclin D1 and c-Myc are attributed to the oncogenic function of b-catenin. In addition to the transcriptional control, our findings indicate that b-catenin may also contribute to tumorigenesis by causing centrosomal abnormalities and genetic instability.
Materials and methods
Cell culture and synchronization A rat fibroblast cell line, 3Y1, was cultured in Dulbecco'smodified Eagle's medium (DMEM) supplemented with 5% newborn bovine serum. For double thymidine block and release experiment, cells were incubated in fresh DMEM containing 2 mM thymidine (Sigma, Saint Louis, MO, USA) for 12-16 h, released for 12 h in DMEM containing 10% fetal bovine serum, and then incubated again in 2 mM thymidine for 12-16 h. After release from double thymidine block, cells were subjected to immunofluorescence and immunoblot.
Reagents and antibodies
Nocodazole was from Cell Signaling Technology (Beverly, MA, USA). Anti-a-and anti-g-tubulin antibodies were purchased from Calbiochem (Darmstadt, Germany). Other antibodies included mouse monoclonal antibodies against b-catenin, GSK-3b, EB1 (Transduction Laboratories, San Jose, CA, USA), rabbit polyclonal antibodies against phospho-bcatenin, phospho-GSK-3b (Cell Signaling), ninein (Biolegend, San Diego, CA, USA). Fluorescein isothiocyanate (FITC)-conjugated a-tubulin, FITC-conjugated g-tubulin, e-tubulin (Sigma) or cyclin B1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Rat b-catenin cDNA was isolated using reverse transcription-polymerase chain reaction (RT-PCR), and then ligated into pcDNA3 vector. S33A and S33/37/T41E mutation in b-catenin cDNA was made by site-directed mutagenesis using PCR, and then ligated into pEGFP-N1 vector.
SiRNA treatment
For siRNA treatment, siRNA oligonucleotides with two thymidine residues (dTdT) at the 3 0 -end were produced by DHARMACON (Lafayette, Colorado, USA). The sequences targeting b-catenin were 5 0 -CUAUCAGGAUGACGCGGAA-3 0 (corresponding to nucleotides 427-436) and 5 0 -AGAGUAG CUGCAGGGGUCC-3 0 (corresponding to nucleotides 1338-1347). A luciferase-targeting siRNA was used as a control. SiRNA was transfected into cells using gene Porter (Gene Therapy Systems, San Diego, CA, USA) or Magnetofection Kit (OZ Biosciences, Marseille cedex, France).
Immunoblotting and immunoprecipitation
Cells were washed with ice-cold phosphate-buffered saline (PBS) and scraped with sample buffer as reported previously (Ruhul Amin et al., 2003) . Equal amount of proteins were electrophoresed on 10% SDS-PAGE (SDS-polyacrylamide gel electrophoresis) and transferred to polyvinylidene difluoride membrane. The membrane was blocked in 5% nonfat skimmed milk, incubated with the primary antibodies followed by the secondary antibodies. Proteins were detected using enhanced chemiluminescence system (Amersham Biosciences, Bockinghamshire, England). For immunoprecipitation experiment, cells were lysed in a lysis buffer containing 50 mM TrisHCl (pH 7.4), 150 mM NaCl, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride and 1% Triton X-100. Lysates were centrifugalized at 15 000 r.p.m. for 20 min at 41C, then the supernatants were incubated with antibodies coupled to protein A-agarose for 2-4 h at 41C. The immunoprecipitates were washed six times with lysis buffer and then subjected to immunoblotting.
Immunofluorescence and microscopy Cells grown on glass coverslips (Matsunami Glass IND, Osaka, Japan) were fixed in 4% paraformaldehyde for 15 min, permeabilized with 0.5% Triton X-100 in PBS for 5 min as previously reported (Liu et al., 2001) . They were then exposed consecutively to primary antibodies and rhodamine-conjugated or FITC-conjugated secondary antibodies. Images were obtained with microscope (BX60; Olympus, Tokyo, Japan) or laser-scanning (Ar 488 nm, HeNe 543 nm) confocal microscope (BX50; Olympus). FLUOVIEW (version 4.3; Olympus) was used for fluorescence intensity measurements of a-tubulin staining at the nucleated MTs. A 1280 Â 1024-pixel, 16-bit image was collected with acquisition parameters (Objective Lens: PLAPO 60 Â 0; PMT Voltage: 620; offset: 6; Gain: 2; Frame Filter: 4 frame Kalman filter). Imaging conditions were identical for all cells. Best focus was based on highest pixel intensity at the center of the nucleated MTs. The relative intensity map within a 5-mm-diameter disk was generated by using FLUOVIEW (yellow color means high intensity and blue color means low intensity, intensity range is available 0-4095). The average relative pixel intensity within a 5-mmdiameter disk in each cell was calculated by using FLUOVEW. Later, the average relative intensity of 100 cells in three independent experiments was calculated and used for quantification of MT regrowth.
Microtubule regrowth
Microtubules were depolymerized by treating with 33 mM nocodazole on ice for 45 min. For regrowth, cells were washed in PBS for three times followed by serum-free medium for another three times, and then incubated in serum-free medium at 371C for 2, 15, 30 or 60 min.
Abbreviations phospho-b-catenin, phosphorylated b-catenin at serine33/37/ threonine41; GSK-3b, Glycogen synthase kinase 3b; MT, microtubule.
